Japanese Biopsy Specialists Prove Covid Shots Cause Deadly Heart Failure
A group of Japanese scientists has used a specialized biopsy technique to finally prove that Covid mRNA shots are causing cases of deadly heart failure to surge around the world.
Dr. Hiroyuki Yamamoto Department of Cardiovascular Medicine, Narita-Tomisato Tokushukai Hospital, Chiba, Japan, led a team of researchers seeking to identify the global spike in cardiac deaths.
The team is made up of several renowned researchers and investigators, including:
- Katsuya Hashimoto, Department of Cardiovascular Medicine, Narita-Tomisato Tokushukai Hospital, Chiba, Japan
- Hiroyuki Yamamoto, Department of Cardiovascular Medicine, Narita-Tomisato Tokushukai Hospital, Chiba, Japan
- Yoshihiko Ikeda, Department of Pathology, National Cerebral and Cardiovascular Center, Suita, Japan
- Jun Isogai, Department of Radiology, Asahi General Hospital, Asahi, Japan
- Toru Hashimoto, Katsuya Hashimoto, Department of Cardiovascular Medicine, Narita-Tomisato Tokushukai Hospital, Chiba, Japan
During their investigations, the team uncovered evidence of vaccine-associated myocarditis or “VAM.”
However, it can often turn fatal as it’s difficult to diagnose, acting like a ticking time bomb that is only revealed when a person suffers a cardiac arrest.
Early diagnosis continues to be tough due to a broad clinical spectrum of phenotypes and pathophysiology, such as minor focal myocarditis, multisystemic inflammatory syndrome, and fulminant myocarditis.
Nevertheless, the researchers note in their study’s paper that “histological evaluation remains to be fully understood.”
The case report features Japanese specialists proving vaccine-associated cardiomyopathy.
The study’s paper was published in ESC Heart Failure.
It features a case report of a 78-year-old previously healthy female referred by her family physician.
The patient was then admitted to the Narita-Tomisato Tokushukai Hospital for management of dyspnea 11 days after receiving the third dose of a Covid shot – the mRNA-1273 (Moderna) injection.
The patient previously underwent a primary two-dose BNT162b2 (Pfizer) series.
Four days after the Moderna jab, “the patient experienced palpitations and dyspnea, which gradually worsened.”
With a history of mild dementia but no risk factors for coronary artery disease, the physician-investigators report the patient had no recent travel history, contact with patients with confirmed COVID-19, recent infectious prodrome, or any history of alcohol consumption, cigarette smoking, or illicit drug use.
The scientists performed a specialized biopsy which proved the patients died from vaccine-induced heart failure.
They performed an endomyocardial biopsy (EMB), noting that regular techniques would likely miss the VAM.
This study features VAM as evidenced by biopsy-proven dilated cardiomyopathy (DCM) – pathological diagnosis of chronic myocarditis and inflammatory cardiomyopathy including (iDCM)
The Japanese specialists revealed that this was the first case of biopsy-proven iDCM ensuing days after heterologous mRNA-1273 immunization.
After performing an EMB, they were able to identify the heart damage and successfully treat it with corticosteroids, saving the patient’s life.
The researchers note that, without the EMB, the patient would have likely died, despite having already been admitted to the hospital, as her condition would have not been detected.
